Advertisement
Singapore markets closed

  • Straits Times Index

    3,415.51
    +47.61 (+1.41%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Bitcoin USD

    60,224.95
    -2,412.67 (-3.85%)
     

  • CMC Crypto 200

    1,292.97
    -41.94 (-3.14%)
     

  • FTSE 100

    8,167.26
    +46.06 (+0.57%)
     

  • Gold

    2,357.80
    +24.40 (+1.05%)
     

  • Crude Oil

    82.88
    +0.07 (+0.08%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • Nikkei

    40,580.76
    +506.07 (+1.26%)
     

  • Hang Seng

    17,978.57
    +209.43 (+1.18%)
     

  • FTSE Bursa Malaysia

    1,615.32
    +17.36 (+1.09%)
     

  • Jakarta Composite Index

    7,196.75
    +71.61 (+1.01%)
     

  • PSE Index

    6,450.03
    +91.07 (+1.43%)
     

UPDATE 2-FDA warns against using Cardinal's syringes

Reuters
·1-min read

(Adds background in paragraphs 4 and 5)

Nov 20 (Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes with patient-controlled pain management pumps and syringe pumps.

The regulator's warning comes after Cardinal Health initiated a recall for its Monoject syringes due to incompatibility concerns with syringe pumps.

Monoject syringes are used to inject into or withdraw fluids from the body while patient-controlled analgesia, or pain management pumps, are used to treat different kinds of pain by transferring medications intravenously.

ADVERTISEMENT

In June, Cardinal Health began distributing the new Monoject syringe, which has different dimensions compared to the company's previous version of the syringes called Covidien.

The FDA said on Monday it is okay to continue using Covidien syringes and that the agency will work with the company to further evaluate the issue with the new syringe. (Reporting by Christy Santhosh; Editing by Maju Samuel)